As of 2025-05-20, the Relative Valuation of Sangamo Therapeutics Inc (SGMO) is (17.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 USD, the upside of Sangamo Therapeutics Inc based on Relative Valuation is -3665.9%.
The range of the Relative Valuation is (15.59) - (17.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 27.2x | 24.9x |
| Forward P/E multiples | 23.8x - 37.9x | 29.5x |
| Fair Price | (15.59) - (17.81) | (17.80) |
| Upside | -3222.8% - -3668.5% | -3665.9% |
| Date | P/E |
| 2025-05-15 | -0.69 |
| 2025-05-14 | -0.67 |
| 2025-05-13 | -0.70 |
| 2025-05-12 | -1.14 |
| 2025-05-09 | -1.07 |
| 2025-05-08 | -1.10 |
| 2025-05-07 | -0.99 |
| 2025-05-06 | -0.94 |
| 2025-05-05 | -1.10 |
| 2025-05-02 | -1.11 |
| 2025-05-01 | -1.13 |
| 2025-04-30 | -1.18 |
| 2025-04-29 | -1.10 |
| 2025-04-28 | -1.13 |
| 2025-04-25 | -1.20 |
| 2025-04-24 | -1.25 |
| 2025-04-23 | -1.15 |
| 2025-04-22 | -1.19 |
| 2025-04-21 | -1.12 |
| 2025-04-17 | -1.08 |
| 2025-04-16 | -1.05 |
| 2025-04-15 | -1.13 |
| 2025-04-14 | -1.15 |
| 2025-04-11 | -1.10 |
| 2025-04-10 | -1.11 |
| 2025-04-09 | -1.07 |
| 2025-04-08 | -0.96 |
| 2025-04-07 | -1.08 |
| 2025-04-04 | -1.00 |
| 2025-04-03 | -0.95 |
| 2025-04-02 | -1.00 |
| 2025-04-01 | -0.87 |
| 2025-03-31 | -1.00 |
| 2025-03-28 | -1.25 |
| 2025-03-27 | -1.31 |
| 2025-03-26 | -1.29 |
| 2025-03-25 | -1.28 |
| 2025-03-24 | -1.33 |
| 2025-03-21 | -1.32 |
| 2025-03-20 | -1.28 |
| 2025-03-19 | -1.33 |
| 2025-03-18 | -1.29 |
| 2025-03-17 | -1.54 |
| 2025-03-14 | -1.50 |
| 2025-03-13 | -1.41 |
| 2025-03-12 | -1.52 |
| 2025-03-11 | -1.52 |
| 2025-03-10 | -1.51 |
| 2025-03-07 | -1.59 |
| 2025-03-06 | -1.53 |